Literature DB >> 30630952

Membrane-associated RING-CH (MARCH) 1 and 2 are MARCH family members that inhibit HIV-1 infection.

Yanzhao Zhang1, Takuya Tada1, Seiya Ozono1,2, Weitong Yao1,3, Michiko Tanaka1, Shoji Yamaoka3, Satoshi Kishigami2, Hideaki Fujita4, Kenzo Tokunaga5.   

Abstract

Membrane-associated RING-CH 8 (MARCH8) is one of 11 members of the MARCH family of RING finger E3 ubiquitin ligases and down-regulates several membrane proteins (e.g. major histocompatibility complex II [MHC-II], CD86, and transferrin receptor). We recently reported that MARCH8 also targets HIV-1 envelope glycoproteins and acts as an antiviral factor. However, it remains unclear whether other family members might have antiviral functions similar to those of MARCH8. Here we show that MARCH1 and MARCH2 are MARCH family members that reduce virion incorporation of envelope glycoproteins. Infectivity assays revealed that MARCH1 and MARCH2 dose-dependently suppress viral infection. Treatment with type I interferon enhanced endogenous expression levels of MARCH1 and MARCH2 in monocyte-derived macrophages. Expression of these proteins in virus-producing cells decreased the efficiency of viral entry and down-regulated HIV-1 envelope glycoproteins from the cell surface, resulting in reduced incorporation of envelope glycoproteins into virions, as observed in MARCH8 expression. With the demonstration that MARCH1 and MARCH2 are antiviral MARCH family members as presented here, these two proteins join a growing list of host factors that inhibit HIV-1 infection.
© 2019 Zhang et al.

Entities:  

Keywords:  HIV; HIV-1; MARCH family; antiviral factor; glycoprotein; host–pathogen interaction; macrophage; membrane protein; membrane-associated RING-CH

Mesh:

Substances:

Year:  2019        PMID: 30630952      PMCID: PMC6416432          DOI: 10.1074/jbc.AC118.005907

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins.

Authors:  Eric Bartee; Mandana Mansouri; Bianca T Hovey Nerenberg; Kristine Gouveia; Klaus Früh
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

2.  Solution structure of the Kaposi's sarcoma-associated herpesvirus K3 N-terminal domain reveals a Novel E2-binding C4HC3-type RING domain.

Authors:  Roger B Dodd; Mark D Allen; Stephanie E Brown; Christopher M Sanderson; Lidia M Duncan; Paul J Lehner; Mark Bycroft; Randy J Read
Journal:  J Biol Chem       Date:  2004-09-30       Impact factor: 5.157

3.  Novel regulation of MHC class II function in B cells.

Authors:  Yohei Matsuki; Mari Ohmura-Hoshino; Eiji Goto; Masami Aoki; Mari Mito-Yoshida; Mika Uematsu; Takanori Hasegawa; Haruhiko Koseki; Osamu Ohara; Manabu Nakayama; Kiminori Toyooka; Ken Matsuoka; Hak Hotta; Akitsugu Yamamoto; Satoshi Ishido
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

4.  Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis.

Authors:  L Coscoy; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

5.  Inhibition of MHC class II expression and immune responses by c-MIR.

Authors:  Mari Ohmura-Hoshino; Yohei Matsuki; Masami Aoki; Eiji Goto; Mari Mito; Mika Uematsu; Terutaka Kakiuchi; Hak Hotta; Satoshi Ishido
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

6.  c-MIR, a human E3 ubiquitin ligase, is a functional homolog of herpesvirus proteins MIR1 and MIR2 and has similar activity.

Authors:  Eiji Goto; Satoshi Ishido; Yuya Sato; Shinji Ohgimoto; Kaori Ohgimoto; Motoko Nagano-Fujii; Hak Hotta
Journal:  J Biol Chem       Date:  2003-02-11       Impact factor: 5.157

7.  MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins.

Authors:  Takuya Tada; Yanzhao Zhang; Takayoshi Koyama; Minoru Tobiume; Yasuko Tsunetsugu-Yokota; Shoji Yamaoka; Hideaki Fujita; Kenzo Tokunaga
Journal:  Nat Med       Date:  2015-11-02       Impact factor: 53.440

8.  MARCH-IX mediates ubiquitination and downregulation of ICAM-1.

Authors:  Simon Hoer; Lorraine Smith; Paul J Lehner
Journal:  FEBS Lett       Date:  2006-12-08       Impact factor: 4.124

9.  MARCH ubiquitin ligases alter the itinerary of clathrin-independent cargo from recycling to degradation.

Authors:  Craig A Eyster; Nelson B Cole; Shariska Petersen; Kasinath Viswanathan; Klaus Früh; Julie G Donaldson
Journal:  Mol Biol Cell       Date:  2011-07-14       Impact factor: 4.138

10.  Ubiquitination by the membrane-associated RING-CH-8 (MARCH-8) ligase controls steady-state cell surface expression of tumor necrosis factor-related apoptosis inducing ligand (TRAIL) receptor 1.

Authors:  Bert van de Kooij; Inge Verbrugge; Evert de Vries; Merel Gijsen; Veronica Montserrat; Chiel Maas; Jacques Neefjes; Jannie Borst
Journal:  J Biol Chem       Date:  2013-01-08       Impact factor: 5.157

View more
  19 in total

1.  The E3 ubiquitin ligase MARCH1 regulates antimalaria immunity through interferon signaling and T cell activation.

Authors:  Jian Wu; Lu Xia; Xiangyu Yao; Xiao Yu; Keyla C Tumas; Wenxiang Sun; Yang Cheng; Xiao He; Yu-Chih Peng; Brajesh K Singh; Cui Zhang; Chen-Feng Qi; Silvia Bolland; Sonja M Best; Channe Gowda; Ruili Huang; Timothy G Myers; Carole A Long; Rong-Fu Wang; Xin-Zhuan Su
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-30       Impact factor: 11.205

2.  Differential Pressures of SERINC5 and IFITM3 on HIV-1 Envelope Glycoprotein over the Course of HIV-1 Infection.

Authors:  Saina Beitari; Qinghua Pan; Andrés Finzi; Chen Liang
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

Review 3.  Updating on Roles of HIV Intrinsic Factors: A Review of Their Antiviral Mechanisms and Emerging Functions.

Authors:  Sudarat Hadpech; Sutpirat Moonmuang; Koollawat Chupradit; Umpa Yasamut; Chatchai Tayapiwatana
Journal:  Intervirology       Date:  2021-08-31       Impact factor: 2.294

4.  The Immune-Specific E3 Ubiquitin Ligase MARCH1 Is Upregulated during Human Cytomegalovirus Infection to Regulate Iron Levels.

Authors:  Madison Martin; Praneet Sandhu; Rinki Kumar; Nicholas J Buchkovich
Journal:  J Virol       Date:  2022-01-19       Impact factor: 6.549

Review 5.  HIV-1 Envelope Glycoprotein at the Interface of Host Restriction and Virus Evasion.

Authors:  Saina Beitari; Yimeng Wang; Shan-Lu Liu; Chen Liang
Journal:  Viruses       Date:  2019-03-30       Impact factor: 5.048

6.  Mechanism of Viral Glycoprotein Targeting by Membrane-associated-RING-CH Proteins.

Authors:  Cheng Man Lun; Abdul A Waheed; Alhlam Majadly; Nicole Powell; Eric O Freed
Journal:  bioRxiv       Date:  2021-01-26

Review 7.  Accelerator or Brake: Immune Regulators in Malaria.

Authors:  Chunmei Cai; Zhiqiang Hu; Xiao Yu
Journal:  Front Cell Infect Microbiol       Date:  2020-12-10       Impact factor: 5.293

8.  MARCH8 inhibits viral infection by two different mechanisms.

Authors:  Yanzhao Zhang; Takuya Tada; Seiya Ozono; Satoshi Kishigami; Hideaki Fujita; Kenzo Tokunaga
Journal:  Elife       Date:  2020-08-11       Impact factor: 8.140

9.  MARCH8 Inhibits Ebola Virus Glycoprotein, Human Immunodeficiency Virus Type 1 Envelope Glycoprotein, and Avian Influenza Virus H5N1 Hemagglutinin Maturation.

Authors:  Changqing Yu; Sunan Li; Xianfeng Zhang; Ilyas Khan; Iqbal Ahmad; Yulong Zhou; Shuo Li; Jing Shi; Yu Wang; Yong-Hui Zheng
Journal:  mBio       Date:  2020-09-15       Impact factor: 7.867

10.  Negative regulation of NEMO signaling by the ubiquitin E3 ligase MARCH2.

Authors:  Kiramage Chathuranga; Tae-Hwan Kim; Hyuncheol Lee; Jun-Seol Park; Jae-Hoon Kim; Wijesinghe A Gayan Chathuranga; Pathum Ekanayaka; Youn Jung Choi; Chul-Ho Lee; Chul-Joong Kim; Jae U Jung; Jong-Soo Lee
Journal:  EMBO J       Date:  2020-09-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.